(Q54338607)

28 May 2018

title

Acute myeloid leukemia in elderly adults. (English)

1 reference

28 May 2018

1 reference

acute myeloid leukemia

1 reference

Tucker J

1

1 reference

28 May 2018

Thomas AE

2

1 reference

28 May 2018

Gregory WM

3

1 reference

28 May 2018

Ganesan TS

4

1 reference

28 May 2018

Malik ST

5

1 reference

28 May 2018

Amess JA

6

1 reference

28 May 2018

Lim J

7

1 reference

28 May 2018

Willis L

8

1 reference

28 May 2018

Rohatiner AZ

9

1 reference

28 May 2018

Lister TA

10

1 reference

28 May 2018

publication date

1 January 1990

1 reference

28 May 2018

published in

Hematological Oncology

1 reference

28 May 2018

volume

8

1 reference

28 May 2018

issue

1

1 reference

28 May 2018

page(s)

13-21

1 reference

28 May 2018

Treatment of acute myeloid leukaemia with a triple cytotoxic regime: dat

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

Hypoplastic acute myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

Treatment of acute nonlymphocytic leukemia in young and elderly patients.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

Short-term treatment for acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

Treatment of acute leukaemia with m-AMSA in combination with cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

Difference between young and old patients in characteristics of leukemic cells: older patients have cells growing excessively in vitro, with low antigenicity despite high HLA-DR antigens

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

Treatment of acute non-lymphoblastic leukaemia in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

A prognostic factor analysis for use in development of predictive models for response in adult acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

Improved prospects for long-term survival in adults with acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

Correlation between chromosomal pattern, cytological subtypes, response to therapy, and survival in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

Treatment of acute nonlymphocytic leukemia in elderly patients: a prospective study of intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

Acute myeloblastic leukemia in elderly patients: treatment and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

Short-term therapy for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

A comparison of two schedules of cytosine arabinoside used in combination with adriamycin and 6-thioguanine in the treatment of acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

Features affecting outcome during remission induction of acute myeloid leukaemia in 619 adult patients.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

Prognostic value of cytologic parameters in acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080103

7 January 2021

Identifiers

DOI

10.1002/HON.2900080103

1 reference

28 May 2018

1 reference

28 May 2018